Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer

The case of a 70-year-old man who developed Lambert-Eaton myasthenic syndrome (LEMS) while receiving atezolizumab treatment for extensive-stage small-cell lung cancer (SCLC) is presented. He started receiving maintenance immunotherapy with atezolizumab following four cycles of combination therapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazoe, Masami, Hatakeyama, Taku, Furukawa, Kento, Kato, Koji, Horiuchi, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908354/
https://www.ncbi.nlm.nih.gov/pubmed/36779131
http://dx.doi.org/10.7759/cureus.33557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908354/
https://www.ncbi.nlm.nih.gov/pubmed/36779131
http://dx.doi.org/10.7759/cureus.33557

Ejemplares similares